Skip to content

Study on the correct use of drugs in patients with infarction

Medication adherence in patients with a history of Myocardial Infarction: randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
REBEC
Registry ID
RBR-2gbqfx
Enrollment
Unknown
Registered
2020-05-25
Start date
2020-08-03
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial infarction

Interventions

On the occasion of the first meeting, all participants, from both groups, will be submitted to an interview for sociodemographic and clinical characterization, intention to take the medication and ass
Behavioural

Sponsors

Universidade Estadual de Campinas
Lead Sponsor
Universidade Estadual de Campinas
Collaborator

Eligibility

Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients with myocardial infarction; both genders; age over 18 years; using cardioprotective drugs; social referent responsible for organizing and taking pills

Exclusion criteria

Exclusion criteria: Patients without conditions for effective oral verbal communication; diagnosed with mental disorders; social referent who cannot be present in the interviews

Design outcomes

Primary

MeasureTime frame
Increased medication adherence to cardioprotectors among patients with a history of myocardial infarction, verified by means of a paired Wilcoxon test, based on the finding of increased medication adherence measures after intervention

Secondary

MeasureTime frame
Improvement of serum cholesterol level, blood pressure and peripheral pulse rate, verified by means of a paired Wilcoxon test, based on the finding of a reduction of at least 5% in the post-intervention measurements;The intervention is feasible, verified by the rate of patient participation, based on the observation that 70% of eligible patients participated in all stages of the study;The intervention is easy to apply, verified by the debriefing method with patients, based on the observation that all participants adhered to the intervention

Countries

Brazil

Contacts

Public ContactRafaela Pedrosa

Universidade Estadual de Campinas

rpedrosa@unicamp.br+55-019-983015493

Outcome results

None listed

Source: REBEC (via WHO ICTRP)